Product description

Bifiasthm is a probiotic product proposed for children with asthma, in order to prevent asthmatic crises and support the balance of the immune system reactivitity. Bifiasthm is based on B. breve B632 and L. salivarius LS01, two strains with immunomodulatory activity targeted for allergic asthmatic subjects. A placebo-controlled clinical trial pending publication in 2020 and involving 500 asthmatic children showed that Bifiasthm was able to reduce significantly the episodes of asthma.

Read more

Specifications

Categories Finished Dosage Forms; Natural ExtractsFunctional Food And Nutraceutical Ingredients; APIs (Active Pharmaceutical Ingredients)Probiotics
Sales markets Western Europe; Eastern Europe; Middle East Region (e.g. UAE); Asia; Oceania; North America (USA, Canada); Africa; Central/South America
Supplied from Italy
Selling Points Product Features; Quality Service

More products from Probiotical S.p.A.

View all our products (26)

Products from other suppliers